Its overexpression significantly suppresses invasive capability in lung cancer by reducing the expression levels of several actin remodeling-related genes [39], a finding that is in agreement with the role of HOXA5 in AT remodeling in obesity conditions [11]. The gene discussed is HOXA5; the disease is obesity due to melanocortin 4 receptor deficiency.